Publications library

Home

/

Publication Library Listing

Publications

Oncology

Centers of Excellence

Newest to Oldest

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands

Authors: M J H G Simons, P M Machielsen, J A Spoorendonk, T Ignacio, P B Drost, T Jacobs, F E de Jongh

Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia

Authors: P J Goebell, R Raina, S Chen, S Rege, R Shah, J P Grossman, A R Waldeck

Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments

Authors: M Yang, E Mandal, F X Liu, R M O'Hara Jr, B Lesher, R E Sanborn

Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

Authors: M Boeri, M K Skelsey, J A Schiro, S E Dozier, R Glinert, M M Okun

Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH)

Authors: V McLaughlin, A Alsumali, R Liu, R Klok, E C Martinez, I Nourhussein, D Bernotas, J Chevure, C Pausch, J D O Pena, D Lautsch & M M Hoeper

Perspectives of healthcare professionals on the management and treatment of advanced ovarian cancer in the UK: results from the KNOW-OC survey

Authors: C Fotopoulou, M Hall, R Lord, R Miller, S Sundar, N Roebuck, L Fildes, A Wesselbaum, S McCormack, J Hickey, J Ledermann

Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer

Authors: J Garside, Q Shen, B Westermayer, M van de Ven, S Kroep, V Chirikov, I Juhasz-Böss

Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective

Authors: N Dhanji, T Cristina Decimoni, M T D Dyer , J R May, G van de Wetering, S Petersohn, K Nickel, A Silva, D Q B Muniz, A P C D Oliveira

Retrospective comparison of survival projections for CAR T-Cell therapies in large B-Cell lymphoma

Authors: E F P Peterse, E J M Verburg-Baltussen, A Stewart, F F Liu, C Parker, M Treur, B Malcolm, S L Klijn

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

Authors: C Palmieri, A Musson, C Harper-Wynne, D Wheatley, G Bertelli, I R Macpherson, M Nathan, E McDowall, A Bhojwani, Mark Verrill, J Eva, C Doody, R Chowdhury

View older